Highlights

  • Mesoblast shares declined 0.21% during the latest ASX trading session.
  • The stock traded between AUD 2.285 and AUD 2.380 during the session.
  • Mesoblast had a market capitalisation of AUD 2.89B during the latest trading.

Mesoblast Limited (ASX:MSB) shares edged lower during the latest trading session, declining 0.21% to AUD 2.345 from the previous close of AUD 2.350. The biotechnology company, which operates in the Pharmaceuticals, Biotechnology & Life Sciences industry group, recorded modest price movement as investors monitored activity on the Australian Securities Exchange. During the session, the shares traded within an intraday range of AUD 2.285 to AUD 2.380 before closing marginally lower.

Trading Volume Remains Below Average

Mesoblast recorded trading volume of 2,045,818 shares during the latest session, below its average daily trading volume of 3,417,798 shares. The bid price stood at AUD 2.340, while the offer price was AUD 2.350 during trading. Although the stock experienced only a marginal decline, trading activity remained below its average daily level, indicating lighter market participation during the session.

Shares Continue Trading Within Their 52-Week Range

The latest share price remained within Mesoblast's 52-week trading range of AUD 1.630 to AUD 3.310. The stock continued to trade above its annual low while remaining below its highest level recorded over the past year. Investors frequently monitor the 52-week range to compare current trading levels with historical price performance and assess market trends.

Market Capitalisation and Share Information

Mesoblast had a market capitalisation of approximately AUD 2.89B during the latest trading session. The company has been listed on the Australian Securities Exchange since 16 December 2004 and has 1,294,612,776 ordinary fully paid shares on issue under ISIN AU000000MSB8. The company operates within the Pharmaceuticals, Biotechnology & Life Sciences industry group on the ASX.

Latest Trading Snapshot

The latest market data showed Mesoblast closing at AUD 2.345 after declining 0.21% during the session. The shares traded between AUD 2.285 and AUD 2.380 while recording trading volume below the average daily level. With a market capitalisation of AUD 2.89B, the stock continued to trade within its established 52-week trading range.

Key Risks

  • Biotechnology sector developments may influence investor sentiment.
  • Clinical and regulatory outcomes may affect share performance.
  • Lower trading volumes may increase price volatility.
  • Broader market conditions may impact healthcare stocks.

Summary

Mesoblast Limited (ASX:MSB) shares declined 0.21% to AUD 2.345 during the latest trading session. The stock traded between AUD 2.285 and AUD 2.380 while recording trading volume below its average daily level. Mesoblast had a market capitalisation of AUD 2.89B, with the shares remaining within their 52-week trading range of AUD 1.630 to AUD 3.310.